Biotech news on March 24, 2026

1. 0101:00 UTC

   Phase 3 STAR study of efdamrofusp alfa meets primary endpoint

   2 outlets · first: Pr Newswire Clinical trial Mostly press releases

   Machine summary The Phase 3 Registration STAR Study of efdamrofusp alfa (IBI302) met its primary endpoint, according to a press release. The release states that the treatment is the first self-developed extended-interval treatment for nAMD in China.

   1. The press release states that the treatment is the first self-developed extended-interval treatment for nAMD in China.

   Reported by Pr Newswire and manilatimes.net.

   • Efdamrofusp Alfa (IBI302)

2. 0215:45 UTC

   Fosun Pharma announces 2025 annual results

   2 outlets · first: manilatimes.net Pharma

   Machine summary Fosun Pharma announced its 2025 annual results.

   Reported by manilatimes.net and thailand-business-news.com.

   • Fosun Pharma

   Full coverage: every report, when each was published, and who was named (2 outlets)

3. 0322:15 UTC

   Coverage recordfinance.yahoo.com: “Analyst Sentiment Unchanged After Codexis (CDXS) Earnings”

   2 outlets · first: finance.yahoo.com Pharma

   The outlets that reported this event are listed with links to their reports; no summary of ours passed our automated checks for it, which says nothing about the event (how they work).

   Reported by finance.yahoo.com and Insider Monkey.

   • Codexis

4. 0422:00 UTC

   Redwood AI to Showcase Platform at BIO-Europe Spring 2026

   2 outlets · first: hk.marketscreener.com Pharma

   Machine summary Key facts from the reports:

   1. BIO-Europe Spring is described in the report titles as Europe's largest springtime biotech partnering event.

   Reported by hk.marketscreener.com and finanznachrichten.de.

   • Redwood AI
   • BIO-Europe Spring 2026

5. 0516:15 UTC

   Quality Care India signs MoU with Intuitive to expand robotic-assisted surgery

   1 outlet · first: biospectrumindia.com Pharma

   Machine summary BioSpectrum India reported that Quality Care India signed a memorandum of understanding with Intuitive to expand robotic-assisted surgery in Tier 2 and Tier 3 markets.

   Reported by biospectrumindia.com.

   • Quality Care India
   • Intuitive

   Full coverage: every report, when each was published, and who was named (1 outlet)

Each summary and its key facts are a machine summary of the reports linked under it; the outlets, times and counts come from those reports' own records. How a rundown is built.